Lifecore Biomedical, Inc. De (LFCR) Revenue (2010 - 2025)

Lifecore Biomedical's Revenue history runs 16 years deep, the most recent figure standing at $36.4 million for Q2 2025.

• In Q2 2025, Revenue fell 3.81% year-over-year to $36.4 million; the TTM figure through May 2025 stood at $128.9 million (changed 0.47% YoY), while the FY2025 annual figure was $128.9 million, changed 0.47% from the prior year.
• Revenue was $36.4 million for Q2 2025 at Lifecore Biomedical, up from $35.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $44.9 million in Q2 2021 to a low of $21.9 million in Q4 2022.
• Historically, Revenue has averaged $30.2 million across 5 years, with a median of $29.1 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Revenue tumbled 81.82% in 2021, then soared 37.9% in 2023.
• A 5-year view of Revenue shows it stood at $25.6 million in 2021, then declined by 14.6% to $21.9 million in 2022, then surged by 37.9% to $30.2 million in 2023, then grew by 8.01% to $32.6 million in 2024, then climbed by 11.91% to $36.4 million in 2025.
• The last three Revenue figures came in at $36.4 million (Q2 2025), $35.2 million (Q1 2025), and $32.6 million (Q4 2024), per Business Quant data.